Kenalog-40 intravenously, intraarticular 40mg-1ml №5

Use: Kenalog 40 is used systemically for bronchial asthma, chronic bronchitis with broncho-obstructive syndrome, pemphigoid, psoriasis, dermatitis. Intra-articular administration is also indicated for chronic diseases. For the treatment of hay fever and other seasonal allergic diseases, one injection of Kenalog 40 mg/ml per year during the pollen season is usually sufficient. How to take: Corticosteroid (GCS) dosage is determined individually, depending on the nature of the disease and therapeutic goals. If multiple injections are required, an interval of at least 4 weeks between administrations should be observed. For intra-articular administration, the dose is determined by the size of the joint and the severity of symptoms. Typically, for adults and children over 12 years of age, the following doses are used: - for small joints (e.g., finger and toe phalanges) - up to 10 mg; - for medium-sized joints (e.g., shoulder) - up to 40 mg. Kenalog 40 is not recommended for intravenous administration. Contraindications: Kenalog 40 mg/ml should not be administered intramuscularly to children under 12 years of age and adolescents under 16 years of age. The drug is contraindicated during pregnancy and breastfeeding. It is used with caution in renal dysfunction. Relative contraindications include: - history of gastric and duodenal ulcers, - severe muscle diseases, - diverticulitis, - fresh intestinal anastomoses, - tendency to thrombosis and embolism, - carcinomas with a tendency to metastasize, - diabetes mellitus, - acute glomerulonephritis, - chronic nephritis, - swelling of lymph nodes during the period after BCG immunization. For local application, contraindications are: - chickenpox, - post-immunization conditions, - tuberculous or syphilitic skin lesions, - fungal diseases, - bacterial skin lesions, - perioral inflammation.